The goal of this clinical trial is to find out whether a pharmacist-led tele-educational program (PharmaTE trial) can help people with type 2 diabetes manage their condition better.
The main questions this study aims to answer are:
1. Does the PharmaTE trial improve blood sugar control (HbA1c levels)? 2. Does it help patients better understand their condition? 3. Does it increase how well patients follow their medication schedule? 4. Does it improve the quality of life for patients with type 2 diabetes? 5. Is this type of tele-education program feasible and acceptable for patients?
Participants will:
Be randomly placed into one of two groups:
Intervention group: Receive five virtual education sessions with a clinical pharmacist over the phone or via Zoom (each lasting 20-30 minutes), in addition to their usual diabetes care.
Control group: Continue receiving standard diabetes care from their healthcare team without the additional pharmacist-led sessions.
Complete assessments at the beginning and end of the study. These include:
A blood test for HbA1c
, Questionnaires on diabetes knowledge, medication adherence, and quality of life
Some participants in the intervention group will be invited for interviews after the sessions to share their experiences and opinions about the program.
Who can join? Adults aged 18-65 with uncontrolled type 2 diabetes (HbA1c \> 7%), receiving care at Ibrahim Bin Hamad Obaidullah Hospital in Ras Al-Khaimah, who speak Arabic and can provide consent.
Patients diagnosed with uncontrolled type 2 diabetes (defined as glycated haemoglobin [HbA1c] >7%) within the previous 12 months
Adults (18 to 65 years) of either gender
Prescribed at least one antidiabetic medication
Have access to either a telephone or a mobile phone
Under 18 years old
Pregnant ladies
Patients admitted to the emergency department
Patients with severe hepatic or renal dysfunction
Rabia Hussain
Lead sponsor
Universiti Sains Malaysia
Sponsor institution
Universiti Sains Malaysia
Collaborator